Ovarian carcinoma First-line therapy in combination with a platinum compound for the treatment of advanced metastatic carcinoma of the ovary. Second-line therapy for the treatment of advanced metastatic carcinoma of the ovary. Breast carcinoma Adjuvant treatment of node-positive breast cancer administered sequentially to standard combination therapy. Therapy after relapse within 6 months of adjuvant […]
Indication : Breast cancer Non-small cell lung cancer Prostate cancer Gastric adenocarcinoma Head and neck cancer Ovarian cancer Compositions : Each mL contain Docetaxel trihydrate 21.34 mg ~ Docetaxel 20 mg Storage Condition : Do not store above 30°C. Store in the original package in order to protect from light. Keep out the
Indication : KEMODOXIN® is indicated for regression in disseminated neoplastic conditions such as acute leukemia, Wilms tumor, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, ovarian carcinoma, transitional cell bladder carcinoma, thyroid carcinoma, lung cancer, Hodgkin’s disease and non-Hodgkin’s lymphoma, bronchogenic carcinoma, and gastric carcinoma. Compositions : Each mL contain Doxorubicin hydrochloride 2 mg
Indication :Â Epirubicin HCl administered as single agent has shown to produce regression in a broad spectrum of tumors including mammary carcinoma, malignant lymphomas, soft tissue sarcomas and gastric cancer. Preliminary findings indicate that the drug has produce some anti tumor activity in malignant melanoma and in advanced colorectal carcinoma. Given in combination with other
Indication : advanced ovarian carcinoma small cell and non small cell carcinoma of the lung squamous cell carcinoma of the head and neck advanced transitional cell carcinoma of the bladder significant responses have been observed when KEMOBOTIN® employed in the treatment of carcinoma of the cervix. KEMOBOTIN® is frequently used in combination with other chemotherapeutic
Indication : Non-small cell lung cancer Pancreatic cancer Bladder cancer Breast cancer Ovarian cancer Other therapeutic activity: Gemcitabine alone or in combination has shown activity in advanced breast and ovarian cancer. Compositions : Each mL contain Gemcitabine hydrochloride 43.27 mg ~ Gemcitabine 38.005 mg Storage Condition : Store in refrigerator (2 – 8°C).
Ovarian carcinoma First-line therapy in combination with a platinum compound for the treatment of advanced metastatic carcinoma of the ovary. Second-line therapy for the treatment of advanced metastatic carcinoma of the ovary. Breast carcinoma Adjuvant treatment of node-positive breast cancer administered sequentially to standard combination therapy. Therapy after relapse within 6 months of adjuvant
Indication : Breast cancer Non-Small cell lung cancer Prostate cancer Gastric adenocarcinoma Head and neck cancer Ovarian cancer Compositions : Each mL contain Docetaxel trihydrate 21.34 mg ~ Docetaxel 20 mg Storage Condition : Do not store above 30°C. Store in the original package in order to protect from light. Keep out the
Indication : Doxorubicin HCl is indicated for regression in disseminated neoplastic conditions such as acute leukemia, Wilms tumor, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, ovarian carcinoma, transitional cell bladder carcinoma, thyroid carcinoma, lung cancer, Hodgkin’s disease and non-Hodgkin’s lymphoma, bronchogenic carcinoma, and gastric carcinoma. Compositions : Each mL contain Doxorubicin hydrochloride 2
Indication :Â Epirubicin HCl administered as a single agent has shown to produce regression in a broad spectrum of tumours including mammary carcinoma, malignant lymphomas, soft tissue sarcomas and gastric cancer. Prelimenary findings indicate that the drug has produced some anti tumor activity in malignant melanoma and in advanced colorectal carcinoma. Given in combination with
Indication : Advanced ovarian carcinoma Small cell and non small cell carcinoma of the lung Squamous cell carcinoma of the head and neck Advanced transitional cell carcinoma of the bladder Significant responses have been observed when Carboplatin employed in the treatment of carcinoma of the cervix. Carboplatin is frequently used in combination with other chemotherapeutic
Indication : Non-small cell lung cancer: Pancreatic cancer: Bladder cancer: Breast cancer: Ovarian cancer: Other therapeutic activity: Gemcitabine alone or in combination has shown activity in advanced breast and ovarian cancer. Compositions : Each mL contain Gemcitabine hydrochloride 43.27 mg ~ Gemcitabine 38.005 mg Storage Condition : Store in refrigerator (2 – 8°C).
Contact CKD OTTO Pharma now for more information about our products and services.
